Abstract
Background: Fixed-dose combination antiretroviral therapy administered as a singletablet regimen (STR) may improve virologic suppression rates. The effect of STRs on development of resistance when virologic failure occurs on STRs is not known.
Original language | English |
---|---|
Pages (from-to) | 2531-2539 |
Number of pages | 9 |
Journal | AIDS (London, England) |
Volume | 28 |
Issue number | 17 |
DOIs | |
Publication status | Published - 2014 |
Keywords
- Antiretroviral treatment
- Atripla
- HIV-1 resistance
- Single-tablet regimen
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases
- Medicine(all)